Pancreatic cancer enhances HER2 signaling through DUSP6 to circumvent therapeutic MAPK inhibition.

被引：0
|
作者：
Bulle, Ashenafi Shiferaw [1 ,2 ]
Seehar, Kuljeet [1 ,2 ]
Bansod, Sapana [1 ,2 ]
Chen, Yali [1 ,2 ]
Hung-Po, Chen [1 ,2 ]
Dodhiawala, Paarth B. [1 ,2 ]
Li, Lin [1 ,2 ]
Somani, Vikas [1 ,2 ]
Mudd, Jacqueline [1 ,2 ]
Fields, Ryan C. [1 ,2 ]
Knoerzer, Deborah [3 ]
Wang-Gillam, Andrea [1 ,2 ]
Kian-Huat, Lim [1 ,2 ]
机构：
[1] Washington Univ, Sch Med, Barnes Jewish Hosp, St Louis, MO USA
[2] Washington Univ, Sch Med, Alvin J Siteman Comprehens Canc Ctr, St Louis, MO USA
[3] 23BioMed Valley Discoveries, Kansas City, MO USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
DS-8201a; DUSP6; HER2; KRAS; ulixertinib; pancreatic ductal adenocarcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5333
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer
    Borrero-Garcia, Luis D.
    del Mar Maldonado, Maria
    Medina-Velazquez, Julia
    Troche-Torres, Angel L.
    Velazquez, Luis
    Grafals-Ruiz, Nilmary
    Dharmawardhane, Suranganie
    BMC CANCER, 2021, 21 (01)
  • [32] Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer
    Luis D. Borrero-García
    Maria del Mar Maldonado
    Julia Medina-Velázquez
    Angel L. Troche-Torres
    Luis Velazquez
    Nilmary Grafals-Ruiz
    Suranganie Dharmawardhane
    BMC Cancer, 21
  • [33] Oestrogen receptor and HER2 differentially activate ERK/MAPK signaling pathway in breast cancer: A large cohort study
    Jerjees, D.
    Abduljabbar, R.
    Nolan, C.
    Green, A.
    Ellis, I.
    Rakha, E.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 260 - 260
  • [34] N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer
    Yang, Jing
    Xu, Penghui
    Chen, Zetian
    Zhang, Xing
    Xia, Yiwen
    Fang, Lang
    Xie, Li
    Li, Bowen
    Xu, Zekuan
    CANCER LETTERS, 2023, 558
  • [35] The differential regulation of tumor suppressor genes (SAMD9, SPRED1, TGFBI, DUSP6, CDX2, TP53) and MAPK/ERK signaling pathway in colorectal cancer
    Rasool, Mahmood
    Alhassan, Khalid I.
    Karim, Sajjad
    Haque, Absarul
    Mutwakil, Mohammed H. Z.
    Alharthi, Mohammed
    Chaudhary, Adeel G.
    Pushparaj, Peter Natesan
    ASIAN JOURNAL OF AGRICULTURE AND BIOLOGY, 2024, 2024 (04):
  • [36] MUC4-Mediated Regulation of Acute Phase Protein Lipocalin 2 through HER2/AKT/NF-κB Signaling in Pancreatic Cancer
    Kaur, Sukhwinder
    Sharma, Neil
    Krishn, Shiv Ram
    Lakshmanan, Imay
    Rachagani, Satyanarayana
    Baine, Michael J.
    Smith, Lynette M.
    Lele, Subodh M.
    Sasson, Aaron R.
    Guha, Sushovan
    Mallya, Kavita
    Anderson, Judy M.
    Hollingsworth, Michael A.
    Batra, Surinder K.
    CLINICAL CANCER RESEARCH, 2014, 20 (03) : 688 - 700
  • [37] DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB
    Wang, Xuliren
    Chi, Weiru
    Ma, Yuwei
    Zhang, Qi
    Xue, Jingyan
    Shao, Zhi-Ming
    Xiu, Bingqiu
    Wu, Jiong
    Chi, Yayun
    TRANSLATIONAL ONCOLOGY, 2024, 46
  • [38] HER2 antibodies pertuzumab and trastuzumab differ in their effect on cell signaling and growth inhibition in breast cancer cells
    Le, Xiaofeng
    Mao, Weiqun
    Lu, Yiling
    Mills, Gordon B.
    Bast, Robert C., Jr.
    CANCER RESEARCH, 2006, 66 (08)
  • [39] A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells
    Hagan, Christy R.
    Knutson, Todd P.
    Lange, Carol A.
    NUCLEIC ACIDS RESEARCH, 2013, 41 (19) : 8926 - 8942
  • [40] Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer
    Garcia-Parra, Jetzabel
    Dalmases, Alba
    Morancho, Beatriz
    Arpi, Oriol
    Menendez, Silvia
    Sabbaghi, MohammadA
    Zazo, Sandra
    Chamizo, Cristina
    Madoz, Juan
    Eroles, Pilar
    Servitja, Sonia
    Tusquets, Ignasi
    Yelamos, Jose
    Lluch, Ana
    Arribas, Joaquin
    Rojo, Federico
    Rovira, Ana
    Albanell, Joan
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2725 - 2734
12345